"To see such a strong response among patients, achieving

New Post Public Reply Private Reply Replies (1) Message Board
daydreaming2
"To see such a strong response among patients, achieving clear to almost clear skin without serious side effects—the downside of biologics—in such a short period of time, is exceptional." Leo (Cellceutix CEO)

great job on phase 2 meet endpoints! phase 1 showed 300mg no SAEs look for a strong phase 3 or 2/3!

Not mention that Prurisol is the dark horse, the risky play in the lounge right now.

Short and distort want this news to go away, they have down played energy positive news redhead the last 1 1/2 years.... Notice their focus is completely on prurisol and talking down the facts and already creating as many delays as they can. Watch to see their play on the next news, you will see who your manipulators are if you haven't already! They are about to run out of juice! May be easy to play in the minds of small retail, but retail won't be the ones buying everything up soon!

http://cellceutix.com/cellceutix-phase-2-tria...Kwhhb.dpbs

http://cellceutix.com/cellceutix-provides-add...nrhJ2.dpbs

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
If you try to defend yourself against lies of the board moderators your post will be deleted. Just like the board they claim to be better than!!! Watch who you trust especially the "long term investors" that support the real attackers!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

ANI Pharmaceuticals to Showcase Research on Membranous Nephropathy

Updated Category News Views 167

ANI Pharmaceuticals to Present Research at ASN Kidney Week 2024 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is set to unveil exciting new pre-clinical data regarding its membranous nephropathy (MN) research. The presentations will take place during two poster sessions at the esteemed American Society of Nephrology (ASN) Kidney Week 2024. The Significance of the ASN Kidney...

Continue Reading
Alexander & Baldwin Reveals Details of 2024 Dividend Payments

Updated Category News Views 205

Alexander & Baldwin's Dividend Announcements for 2024 Alexander & Baldwin, Inc. (NYSE: ALEX) has recently shared significant details regarding the allocation of dividend distributions for the year 2024. This announcement underscores the company's commitment to providing valuable returns to its shareholders while enhancing its operations within the commercial real estate...

Continue Reading
Northern 2 VCT PLC Subscription Offer Fully Secured

Updated Category News Views 162

Update on Subscription Offer by Northern 2 VCT PLC Northern 2 VCT PLC has completed a significant milestone in its financing efforts. The company recently announced that its offer for new ordinary shares for subscription is now fully subscribed, raising a total of up to £10 million. This development comes ahead of the allotment date, signaling a strong interest in the...

Continue Reading
Georgia Power Launches Flexible Payment Plans for Customers

Updated Category News Views 181

Georgia Power Introduces New Payment Options for Customers In an effort to assist customers affected by recent disasters, Georgia Power has rolled out its innovative Installment Payment Plans. This initiative allows customers to spread their current account balance over several months, making it easier for them to manage their finances as they recover. Flexible Payment...

Continue Reading
Exciting New Luxury Home Community Launch in Springs Soon

Updated Category News Views 61

Toll Brothers Announces Foxtail Crossing Community Toll Brothers, Inc. (NYSE:TOL), recognized as a leader in luxury home construction, has unveiled plans for its upcoming community, Foxtail Crossing. This new venture aims to cater to the growing demand for upscale living spaces while providing an array of customization options for home buyers. Located conveniently at the...

Continue Reading